Variants resistant to compounds specifically targeting HCV are observed in clinical trials. A multi-variant viral dynamic model was developed to quantify the evolution and in vivo fitness of variants in subjects dosed with monotherapy of an HCV protease inhibitor, telaprevir. Variant fitness was estimated using a model in which variants were selected by competition for shared limited replication space. Fitness was represented in the absence of telaprevir by different variant production rate constants and in the presence of telaprevir by additional antiviral blockage by telaprevir. Model parameters, including rate constants for viral production, clearance, and effective telaprevir concentration, were estimated from 1) plasma HCV RNA levels o...
Resistance to hepatitis C virus (HCV) inhibitors targeting viral enzymes has been observed in in vit...
BACKGROUND: Telaprevir (TVR) is a hepatitis C virus (HCV) NS3.4A protease inhibitor that has exhibit...
Due to the highly restricted species-tropism of Hepatitis C virus (HCV) a limited number of animal m...
Background: In patients with genotype 1 chronic hepatitis C infection, telaprevir (TVR) in combinati...
<div><p>For patients infected with hepatitis C virus (HCV), the combination of the direct-acting ant...
For patients infected with hepatitis C virus (HCV), the combination of the direct-acting antiviral a...
Approximately 170 million people worldwide are infected with hepatitis C virus (HCV). Current therap...
<div><p>We propose an integrative, mechanistic model that integrates in vitro virology data, pharmac...
<div><h3>Background</h3><p>In patients with genotype 1 chronic hepatitis C infection, telaprevir (TV...
Groundbreaking new drugs called direct acting antivirals have been introduced recently for the treat...
In patients with genotype 1 chronic hepatitis C infection, telaprevir (TVR) in combination with pegi...
Telaprevir (VX-950) is an orally active, specifically targeted antiviral therapy for hepatitis C vir...
International audienceBackground: Telaprevir (TVR) is a protease inhibitor (PI) used in chronic hepa...
Telaprevir (VX-950) is an orally active, specifically targeted antiviral therapy for hepatitis C vir...
<div><p>As an RNA virus, hepatitis C virus (HCV) is able to rapidly acquire drug resistance, and for...
Resistance to hepatitis C virus (HCV) inhibitors targeting viral enzymes has been observed in in vit...
BACKGROUND: Telaprevir (TVR) is a hepatitis C virus (HCV) NS3.4A protease inhibitor that has exhibit...
Due to the highly restricted species-tropism of Hepatitis C virus (HCV) a limited number of animal m...
Background: In patients with genotype 1 chronic hepatitis C infection, telaprevir (TVR) in combinati...
<div><p>For patients infected with hepatitis C virus (HCV), the combination of the direct-acting ant...
For patients infected with hepatitis C virus (HCV), the combination of the direct-acting antiviral a...
Approximately 170 million people worldwide are infected with hepatitis C virus (HCV). Current therap...
<div><p>We propose an integrative, mechanistic model that integrates in vitro virology data, pharmac...
<div><h3>Background</h3><p>In patients with genotype 1 chronic hepatitis C infection, telaprevir (TV...
Groundbreaking new drugs called direct acting antivirals have been introduced recently for the treat...
In patients with genotype 1 chronic hepatitis C infection, telaprevir (TVR) in combination with pegi...
Telaprevir (VX-950) is an orally active, specifically targeted antiviral therapy for hepatitis C vir...
International audienceBackground: Telaprevir (TVR) is a protease inhibitor (PI) used in chronic hepa...
Telaprevir (VX-950) is an orally active, specifically targeted antiviral therapy for hepatitis C vir...
<div><p>As an RNA virus, hepatitis C virus (HCV) is able to rapidly acquire drug resistance, and for...
Resistance to hepatitis C virus (HCV) inhibitors targeting viral enzymes has been observed in in vit...
BACKGROUND: Telaprevir (TVR) is a hepatitis C virus (HCV) NS3.4A protease inhibitor that has exhibit...
Due to the highly restricted species-tropism of Hepatitis C virus (HCV) a limited number of animal m...